Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Esophagitis × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

OTHER 9 INDUSTRY 2 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 170 Neoplasms 94 Colorectal Neoplasms 79 Stomach Neoplasms 74 Uterine Cervical Neoplasms 63 Carcinoma, Non-Small-Cell Lung 60 Carcinoma, Hepatocellular 49 Prostatic Neoplasms 43 Lung Neoplasms 43 Rectal Neoplasms 40 Esophageal Neoplasms 33 Pancreatic Neoplasms 32 Ovarian Neoplasms 31 Colonic Neoplasms 30 Motor Activity 28 Head and Neck Neoplasms 28 Recurrence 26 Neoplasm Metastasis 26 Lymphoma 23 Small Cell Lung Carcinoma 22 Multiple Myeloma 22 Lymphoma, Non-Hodgkin 22 Polycystic Ovary Syndrome 21 Melanoma 21 Leukemia, Myeloid, Acute 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Pain 18 Nasopharyngeal Carcinoma 16 Fallopian Tube Neoplasms 16 Brain Neoplasms 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡